Product Information
ENDOCET 5-325 MG TABLET is a generic product labeled by Par Health USA, LLC, priced at $0.1195 per EA under NDC 60951060285. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 25, 1999. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325; 5 mg/1; mg/1
Manufacturer
Par Health USA, LLCNDC
60951060285
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040330FDA Approved
6/25/1999
TE Code
AA
On Market Since
5/26/2000
Pharmacological Classes
Price Statistics
The NADAC for ENDOCET 5-325 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 161.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1195 per EA |
|---|---|
| All-time high | $0.1880 (May 14, 2014) |
| All-time low | $0.0457 (Nov 28, 2013) |
| 52-week high | $0.1230 |
| 52-week low | $0.1178 |
| Median price | $0.1102 |
| Average price | $0.1166 |
| Largest weekly change | +284.0% (Jan 22, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENDOCET 5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENDOCET 5-325 MG TABLET, manufactured by Par Health USA, LLC, is $0.1195 per EA (NDC 60951060285), effective Aug 19, 2026.
How has the price of ENDOCET 5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENDOCET 5-325 MG TABLET has risen 161.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ENDOCET 5-325 MG TABLET?
Since Nov 28, 2013, the NADAC for ENDOCET 5-325 MG TABLET has ranged from a low of $0.0457 (Nov 28, 2013) to a high of $0.1880 (May 14, 2014), with a median of $0.1102 per EA.
Are there cheaper alternatives to ENDOCET 5-325 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.0864 per EA — about 28% below ENDOCET 5-325 MG TABLET.
Who manufactures ENDOCET 5-325 MG TABLET?
ENDOCET 5-325 MG TABLET (NDC 60951060285) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.